Wednesday, December 16, 2026, from 9:00 a.m. to 4:15 p.m., and Thursday, December 17, 2026, from 9:00 a.m. to 4:00 p.m.
The purpose of this training program is to facilitate the exchange of experiences on prostate cancer between two countries and two different cultures.
Program
Module 1 - Wednesday, December 16
09:00-10:15 : part 1
Moderators:
Dr. Bülent Karabulut
Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG
- 09:00-09:15 Opening session
Dr. Bülent Karabulut
Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG - 09:15-09:45 The role of active surveillance
Dr D. Benamran, staff physician, Urology division, HUG - 09:45-10:15 PET PSMA in prostate cancer
Pre Valentina Garibotto, M.D., head of Nuclear medicine division, HUG - 10:15-10:30 Coffee Break
10:30-12:00 :part 2
Moderator: Pr. Dr. Mustafa Erman
- 10:30-11:00 Prostatectomy in localized prostate cancer
Pr Massimo Valerio, M.D., head of Urology division and Prostate centre, HUG - 11:00-11:30 Radiotherapy in localized prostate cancer
Pr A. Papachristofilou (USB, to be confirmed) - 11:30-12:00 New paradigms and future directions in metastatic prostate cancer treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 12:00-13:00 Lunch Break
13:00-14:30 : part 3
Moderator: Pr Dr Deniz Tural
- 13:00-13:30 The role of RMN in localized and metastatic prostate cancer
Dr Thomas De Perrot, radiologist, Prostate centre, HUG - 13:00-14:30
- mHSPC Low volume: multidisciplinary approach
Dr Dominik Berthold, oncologist, head of Prostate ceentre, CHUV - mHSPC – High volume: Defining the standard of care
Dr Emre Yekedüz
- mHSPC Low volume: multidisciplinary approach
- 14:30-14:45 Coffee Break
14:45-16:15 : part 4
Moderator:
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG
Dr Gökşen İnanç İmamoğlu
- 14:45-15:15 ARPIs in prostate cancer: patient selection and personalized treatment
Dr Gökşen İnanç İmamoğlu - 15:15-16:15 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG
Module 2 – Thursday, December 17
09:00-10:30 : part 1
Moderator: Dr Umut Varol
- 09:00-09:30 Radioligand therapy in prostate cancer: new standards & future directions
Dr Nicola Bianchetto M.D., Senior Resident, Nuclear medicine division, HUG) - 09:30-10:00 Castration-Resistant Prostate Cancer: Sequencing and Precision Treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 10:00-10:30 RECIST and PCWG3 – clinical practice and trials
Dr Umut Varol - 10:30-10:45 Coffee Break
10:45-12:00 : part 2
Moderator: Dr Meltem Baykara
- 10:45-12:00 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG - 12:00-13:00 Lunch Break
- 13:00-16:00 TTOD Session-Insights and Reflections on Preceptorship
Moderator: Pr Dr Bülent Karabulut
Speakers: Dr Mustafa Erman, Dr Deniz Tural, Dr Gökşen İnanç İmamoğlu, Dr Umut Varol, Dr Meltem Baykara, Dr Emre Yekedüz
Quick facts
Specialized training on prostate cancer
Wednesday, December 16, 2026, from 9:00 a.m. to 4:15 p.m., and Thursday, December 17, 2026, from 9:00 a.m. to 4:00 p.m.
SWISS Foundation for Innovation and Training in Surgery (SFITS)
Rue Gabrielle-Perret-Gentil 4, 1205 Geneva
Registration
Few places available.
To register, please send an email to: